Joanne Wen is an Ophthalmology physician. OpenAlex indexes 77 publications with 2,075 citations (h-index 24); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
908 Jefferson St
Seattle, WA 981042433
Telephone
206-543-7250Registry record last updated 19 Sept 2014.
Clinical trials
- Automated Applanation Tonometry - Updated
Sponsor: Duke University
- Tolerability of an Anesthesia-free Tonometer Tip
Sponsor: Duke University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tarsus Pharmaceuticals, Inc.Program year20241 payment
- Abbott LaboratoriesProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
87.3%Prostaglandin Analog33.4%Latanoprost89%Travoprost4%Tafluprost4%Lumigan3%Part D≥434 patientsCarbonic Anhydrase Inhibitor27.3%Dorzolamide-Timolol67%Dorzolamide Hcl17%Acetazolamide10%Simbrinza4%Brinzolamide2%Azopt1%Part D<11 patients+ 8 more classes in this area
Cardiovascular
8%Beta blocker8%Timolol Maleate96%Betaxolol Hcl4%Part D<11 patientsMusculoskeletal
2.8%Cyclooxygenase Inhibitor2.8%Ketorolac Tromethamine100%Part D≥101 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Detecting disease progression in mild, moderate and severe glaucoma
Current Opinion in Ophthalmology
2022 - Automated Detection of Glaucoma With Interpretable Machine Learning Using Clinical Data and Multimodal Retinal Images
American Journal of Ophthalmology
2021 - Cataract Surgery Is Not Associated with Decreased Risk of Retinal Vein Occlusion
Ophthalmology Science
2021 - Aqueous outflow regulation – 21st century concepts
Publisher
2021
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”